$25 billion medical deal
Medical device manufacturer Boston Scientific is proposing to acquire all the outstanding shares of Guidant Corporation for a combination of cash and stock in a deal worth $25 billion.
Medical device maker
is proposing to acquire all the outstanding shares of Guidant Corporation for a combination of cash and stock in a deal worth $25 billion.
Boston Scientific’s $72 per share proposal represents a premium of approximately 14% over a former $63.43 per share offer for the company from Johnson & Johnson.
Assuming that Boston Scientific and Guidant enter into a definitive agreement by the end of the year, it is anticipated that the proposed transaction will close in the first quarter of 2006.
Boston Scientific has received commitment letters from Bank of America and Merrill Lynch who will finance the transaction.
Boston Scientific employs around 16,000 people and had a revenue of $5.6 billion in 2004.
Register now to continue reading
Thanks for visiting The Engineer. You’ve now reached your monthly limit of news stories. Register for free to unlock unlimited access to all of our news coverage, as well as premium content including opinion, in-depth features and special reports.
Benefits of registering
-
In-depth insights and coverage of key emerging trends
-
Unrestricted access to special reports throughout the year
-
Daily technology news delivered straight to your inbox
Comment: The UK is closer to deindustrialisation than reindustrialisation
But is VAT to blame? Manufacturers are taxed on the value added to a product, lets say a billet of steel is purchased. They add value by shaping and...